These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37794648)

  • 1. Automated analysis of the total choline resonance peak in breast proton magnetic resonance spectroscopy.
    Javor D; Bennani-Baiti BI; Clauser P; Kifjak D; Baltzer PAT
    NMR Biomed; 2024 Feb; 37(2):e5054. PubMed ID: 37794648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.
    Sun K; Chai W; Fu C; Zhan Y; Shen K; Luo X; Yan F
    Eur Radiol; 2016 Jun; 26(6):1565-74. PubMed ID: 26385807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.
    Sodano C; Clauser P; Dietzel M; Kapetas P; Pinker K; Helbich TH; Gussew A; Baltzer PA
    Eur Radiol; 2020 Jun; 30(6):3371-3382. PubMed ID: 32065286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
    Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
    AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
    Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.
    Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR
    Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Proton Magnetic Resonance Spectroscopy and 18F-Fluorocholine PET to Differentiate Benign From Malignant Breast Lesions.
    Wu LA; Yen RF; Shih TT; Chen KL; Wang J
    Clin Nucl Med; 2021 Nov; 46(11):896-903. PubMed ID: 34606485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
    Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
    Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
    J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-field MR spectroscopy in the multiparametric MRI evaluation of breast lesions.
    Cavedon C; Meliadò G; Rossi L; Camera L; Baglio I; Caumo F; Montemezzi S
    Phys Med; 2016 Dec; 32(12):1707-1711. PubMed ID: 27637861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T.
    Meisamy S; Bolan PJ; Baker EH; Pollema MG; Le CT; Kelcz F; Lechner MC; Luikens BA; Carlson RA; Brandt KR; Amrami KK; Nelson MT; Everson LI; Emory TH; Tuttle TM; Yee D; Garwood M
    Radiology; 2005 Aug; 236(2):465-75. PubMed ID: 16040903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
    Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
    Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis.
    Wang X; Wang XJ; Song HS; Chen LH
    Med Oncol; 2015 May; 32(5):160. PubMed ID: 25895597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of MR spectroscopy for characterizing malignant breast lesions using a clinical 3-T scanner.
    Baek HM; Lee YJ
    Breast Cancer; 2015 Sep; 22(5):510-9. PubMed ID: 24390858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS.
    Shin HJ; Baek HM; Ahn JH; Baek S; Kim H; Cha JH; Kim HH
    NMR Biomed; 2012 Dec; 25(12):1349-59. PubMed ID: 22566277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
    Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
    NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality fMRI with perfusion, diffusion-weighted MRI and
    Zhu L; Wang J; Shi H; Tao X
    J Magn Reson Imaging; 2019 Feb; 49(2):423-432. PubMed ID: 30475438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance between contrast enhancement, proton MR spectroscopy, and amide proton transfer imaging in patients with brain tumors.
    Sakata A; Fushimi Y; Okada T; Arakawa Y; Kunieda T; Minamiguchi S; Kido A; Sakashita N; Miyamoto S; Togashi K
    J Magn Reson Imaging; 2017 Sep; 46(3):732-739. PubMed ID: 28252822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.